PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HIMS vs. META
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HIMS and META is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

HIMS vs. META - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hims & Hers Health, Inc. (HIMS) and Meta Platforms, Inc. (META). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%60.00%AugustSeptemberOctoberNovemberDecember2025
36.92%
25.94%
HIMS
META

Key characteristics

Sharpe Ratio

HIMS:

2.52

META:

1.82

Sortino Ratio

HIMS:

3.02

META:

2.70

Omega Ratio

HIMS:

1.39

META:

1.36

Calmar Ratio

HIMS:

3.50

META:

3.64

Martin Ratio

HIMS:

11.61

META:

11.00

Ulcer Index

HIMS:

19.91%

META:

6.09%

Daily Std Dev

HIMS:

91.61%

META:

36.79%

Max Drawdown

HIMS:

-87.29%

META:

-76.74%

Current Drawdown

HIMS:

-18.64%

META:

-3.07%

Fundamentals

Market Cap

HIMS:

$6.10B

META:

$1.55T

EPS

HIMS:

$0.44

META:

$21.20

PE Ratio

HIMS:

63.30

META:

28.90

Total Revenue (TTM)

HIMS:

$995.38M

META:

$116.12B

Gross Profit (TTM)

HIMS:

$762.14M

META:

$94.79B

EBITDA (TTM)

HIMS:

$54.33M

META:

$58.27B

Returns By Period

In the year-to-date period, HIMS achieves a 15.18% return, which is significantly higher than META's 4.66% return.


HIMS

YTD

15.18%

1M

6.30%

6M

36.92%

1Y

234.74%

5Y*

22.98%

10Y*

N/A

META

YTD

4.66%

1M

2.61%

6M

28.75%

1Y

63.54%

5Y*

22.65%

10Y*

23.27%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HIMS vs. META — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIMS
The Risk-Adjusted Performance Rank of HIMS is 9393
Overall Rank
The Sharpe Ratio Rank of HIMS is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of HIMS is 9191
Sortino Ratio Rank
The Omega Ratio Rank of HIMS is 9090
Omega Ratio Rank
The Calmar Ratio Rank of HIMS is 9696
Calmar Ratio Rank
The Martin Ratio Rank of HIMS is 9393
Martin Ratio Rank

META
The Risk-Adjusted Performance Rank of META is 9292
Overall Rank
The Sharpe Ratio Rank of META is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of META is 8989
Sortino Ratio Rank
The Omega Ratio Rank of META is 8989
Omega Ratio Rank
The Calmar Ratio Rank of META is 9696
Calmar Ratio Rank
The Martin Ratio Rank of META is 9292
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HIMS vs. META - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HIMS, currently valued at 2.52, compared to the broader market-2.000.002.004.002.521.82
The chart of Sortino ratio for HIMS, currently valued at 3.02, compared to the broader market-4.00-2.000.002.004.003.022.70
The chart of Omega ratio for HIMS, currently valued at 1.39, compared to the broader market0.501.001.502.001.391.36
The chart of Calmar ratio for HIMS, currently valued at 3.50, compared to the broader market0.002.004.006.003.503.64
The chart of Martin ratio for HIMS, currently valued at 11.61, compared to the broader market-10.000.0010.0020.0030.0011.6111.00
HIMS
META

The current HIMS Sharpe Ratio is 2.52, which is higher than the META Sharpe Ratio of 1.82. The chart below compares the historical Sharpe Ratios of HIMS and META, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.001.502.002.503.003.504.00AugustSeptemberOctoberNovemberDecember2025
2.52
1.82
HIMS
META

Dividends

HIMS vs. META - Dividend Comparison

HIMS has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.33%.


TTM2024
HIMS
Hims & Hers Health, Inc.
0.00%0.00%
META
Meta Platforms, Inc.
0.33%0.34%

Drawdowns

HIMS vs. META - Drawdown Comparison

The maximum HIMS drawdown since its inception was -87.29%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for HIMS and META. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-18.64%
-3.07%
HIMS
META

Volatility

HIMS vs. META - Volatility Comparison

Hims & Hers Health, Inc. (HIMS) has a higher volatility of 20.81% compared to Meta Platforms, Inc. (META) at 9.17%. This indicates that HIMS's price experiences larger fluctuations and is considered to be riskier than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%AugustSeptemberOctoberNovemberDecember2025
20.81%
9.17%
HIMS
META

Financials

HIMS vs. META - Financials Comparison

This section allows you to compare key financial metrics between Hims & Hers Health, Inc. and Meta Platforms, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab